The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b

被引：107
|
作者：
Rice, GPA
Paszner, B
Oger, J
Lesaux, J
Paty, D
Ebers, G
机构：
[1] London MS Clin, London, ON N6A 5A5, Canada
[2] Univ British Columbia, MS Clin, Vancouver, BC V5Z 1M9, Canada
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
10.1212/WNL.52.6.1277
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The fate of the neutralizing antibody (NAB) in MS patients treated with interferons remains unclear. We conducted a follow-up survey of NAB titers in 59 long-term treated patients from the London and Vancouver cohorts of the pivotal trial of interferon beta-1b. NAB were measured with the myxovirus protein A assay and an ELISA, at a mean follow-up that exceeded 8 years. NAB disappeared in the majority of patients.
引用
收藏
页码：1277 / 1279
页数：3
相关论文
共 50 条
  • [1] Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b
    Durelli, L.
    Barbero, P.
    Cucci, A.
    Ferrero, B.
    Ricci, A.
    Contessa, G.
    De Mercanti, S.
    Ripellino, P.
    Lapuma, D.
    Viglietta, E.
    Bergui, M.
    Versino, E.
    Clerico, M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 387 - 397
  • [2] Neutralizing antibodies to interferon β-1b are not associated with disease worsening in multiple sclerosis
    Goodin, D. S.
    Hurwitz, B.
    Noronha, A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (02) : 173 - 187
  • [3] Neutralizing antibodies to interferon β-1b are not associated with disease worsening in multiple sclerosis
    Goodin, D. S.
    Hurwitz, B.
    Noronha, A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (01) : 208 - 210
  • [4] Serum auto antibodies presence in multiple sclerosis patients treated with ß-interferon 1a and 1b
    Speciale, L
    Saresella, M
    Caputo, D
    Ruzzante, S
    Mancuso, R
    Calvo, MG
    Guerini, FR
    Ferrante, P
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S57 - S61
  • [5] The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta
    Rice, G
    ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1297 - 1298
  • [6] Axonal metabolic recovery in multiple sclerosis patients treated with interferon β–1b
    Sridar Narayanan
    Nicola De Stefano
    Gordon S. Francis
    Rozie Arnaoutelis
    Zografos Caramanos
    D. Louis Collins
    Daniel Pelletier
    Barry G. W. Arnason
    Jack P. Antel
    Douglas L. Arnold
    Journal of Neurology, 2001, 248 : 979 - 986
  • [7] Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b
    Narayanan, S
    De Stefano, N
    Francis, GS
    Arnaoutelis, R
    Caramanos, Z
    Collins, DL
    Pelletier, D
    Arnason, BGW
    Antel, JP
    Arnold, DL
    JOURNAL OF NEUROLOGY, 2001, 248 (11) : 979 - 986
  • [8] Restoration of cerebral axonal function in multiple sclerosis patients treated with interferon β-1b
    Narayanan, S
    De Stefano, N
    Francis, GS
    Arnaoutelis, R
    Pelletier, D
    Caramanos, Z
    Arnason, BGW
    Antel, JP
    Arnold, DL
    NEUROLOGY, 2000, 54 (07) : A232 - A232
  • [9] Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-β1b
    Jensen, J
    Krakauer, M
    Sellebjerg, F
    CYTOKINE, 2005, 29 (01) : 24 - 30
  • [10] A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging
    Chiu, A. W.
    Ehrmantraut, M.
    Richert, N. D.
    Ikonomidou, V. N.
    Pellegrini, S.
    McFarland, H. F.
    Frank, J. A.
    Bagnato, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 150 (01): : 61 - 67
12345